Articles about Adipotide peptide before and after from GlycoMetrix.
Page 1 of 1Arrowhead Announces Dosing of First Patient with Anti-Obesity Treatment Adipotide® in a Phase 1 Clinical Trial PASADENA, Calif. July 11, 2012 Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company,
adipotide peptideMyPeptideMatch.com is an independent directory for informational purposes only. We do not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy.
adipotide peptideFrom Wikipedia, the free encyclopedia Prohibitin-targeting peptide 1 Clinical data Trade names Adipotide Other names Prohibitin-TP01; TP01 Legal status Legal status Investigational Identifiers CAS Number 859216-15-2 Prohibitin-tar
adipotide peptide